The Biomedical Sciences Industry Partnership Office (BMSIPO) serves as the national office dedicated to drive technology-business public-private R&D partnerships with strategic biomedical sciences and healthcare companies. This includes multinational biotech, pharmaceutical, diagnostics, digital health and medtech companies, as well as innovative local enterprises.

BMSIPO account manages these strategic companies (strategic to Singapore) and architects R&D partnerships from early discovery and pre-clinical development, translational clinical development, to manufacturing R&D, across the diverse public sector research and clinical institutions in Singapore.

BMSIPO leads and supports key publicly-funded research and clinical R&D programmes such as National Platforms, multi-institutional programmes to develop and execute their industry development strategies.

In addition, BMSIPO drives and supports several national level initiatives in the Health & Human Po...